• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肾母细胞瘤根治性肾切除术后预后因素分析及预测模型的建立

Analysis of prognostic factors and development of a predictive model following radical nephrectomy for Wilms tumor in children.

作者信息

Teng Huaida, Hou Boren, Shi Kui, Li Hang, Wang Jiarong, Shi Junlei, Meng Deguang

机构信息

Department of Surgical Oncology, Baoding Branch of Beijing Children's Hospital, Baoding Children's Hospital, Baoding, Hebei 071000, P.R. China.

出版信息

Oncol Lett. 2025 Sep 1;30(5):506. doi: 10.3892/ol.2025.15252. eCollection 2025 Nov.

DOI:10.3892/ol.2025.15252
PMID:40949891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12427606/
Abstract

Wilms tumor (WT) is a common pediatric renal malignancy that poses significant challenges in clinical management and prognosis. The aim of the present study was to identify prognostic factors affecting outcomes in pediatric patients with WT following radical nephrectomy, to stratify high-risk groups for recurrence, and to develop a predictive model to support clinical decision-making and research in Chinese pediatric WT populations. The present retrospective, single-center study included clinical data from 180 pediatric patients with WT who underwent radical nephrectomy at the Baoding Branch of Beijing Children's Hospital (Baoding, China) between January 2015 and January 2019. Univariate and multivariate analyses were performed to identify prognostic factors, and a prediction model was constructed and validated. Progression-free survival (PFS) and overall survival (OS) were analyzed for all patients. The final follow-up was in July 2024. The results demonstrated that the 5-year OS and PFS rates were 99.6 and 94.3%, respectively. The median OS was 76.9 months (range, 30-101 months) and the median PFS was 75.5 months (range, 29-101 months). During follow-up, 25 patients experienced recurrence and 16 died. Univariate analysis revealed that clinical stage, histological subtype and tumor thrombus were significantly associated with prognosis (P<0.05). Multivariate Cox regression analysis identified advanced clinical stage [stage III-IV; hazard ratio (HR), 4.151; 95% confidence interval (CI), 1.440-11.922; P=0.009] and unfavorable histology (HR, 3.842; 95% CI, 1.592-9.283; P=0.002) as independent prognostic factors. A predictive model incorporating these two variables was established, yielding an area under the receiver operating characteristic curve of 0.755 (95% CI, 0.685-0.816; P<0.001). In conclusion, clinical stage and histological subtype are independent predictors of prognosis in children with WT after radical surgery. A predictive model based on these factors may help estimate individual prognosis and guide clinical management strategies.

摘要

肾母细胞瘤(WT)是一种常见的儿科肾脏恶性肿瘤,在临床管理和预后方面带来了重大挑战。本研究的目的是确定影响小儿WT患者根治性肾切除术后预后的因素,对复发高危组进行分层,并建立一个预测模型,以支持中国儿科WT人群的临床决策和研究。本项回顾性单中心研究纳入了2015年1月至2019年1月期间在北京儿童医院保定分院(中国保定)接受根治性肾切除术的180例小儿WT患者的临床数据。进行单因素和多因素分析以确定预后因素,并构建和验证预测模型。对所有患者分析无进展生存期(PFS)和总生存期(OS)。最后一次随访时间为2024年7月。结果显示,5年总生存率和无进展生存率分别为99.6%和94.3%。中位总生存期为76.9个月(范围30 - 101个月),中位无进展生存期为75.5个月(范围29 - 101个月)。随访期间,25例患者复发,16例死亡。单因素分析显示,临床分期、组织学亚型和肿瘤血栓与预后显著相关(P<0.05)。多因素Cox回归分析确定晚期临床分期[III - IV期;风险比(HR),4.151;95%置信区间(CI),1.440 - 11.922;P = 0.009]和不良组织学(HR,3.842;95% CI,1.592 - 9.283;P = 0.002)为独立预后因素。建立了包含这两个变量的预测模型,受试者工作特征曲线下面积为0.755(95% CI,0.685 - 0.816;P<0.001)。总之,临床分期和组织学亚型是小儿WT根治性手术后预后的独立预测因素。基于这些因素的预测模型可能有助于估计个体预后并指导临床管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/cff675a5f8a8/ol-30-05-15252-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/2e054e9e1542/ol-30-05-15252-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/32a870404273/ol-30-05-15252-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/f7ca836d8ab5/ol-30-05-15252-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/778fbe6fd656/ol-30-05-15252-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/cff675a5f8a8/ol-30-05-15252-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/2e054e9e1542/ol-30-05-15252-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/32a870404273/ol-30-05-15252-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/f7ca836d8ab5/ol-30-05-15252-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/778fbe6fd656/ol-30-05-15252-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63c2/12427606/cff675a5f8a8/ol-30-05-15252-g04.jpg

相似文献

1
Analysis of prognostic factors and development of a predictive model following radical nephrectomy for Wilms tumor in children.儿童肾母细胞瘤根治性肾切除术后预后因素分析及预测模型的建立
Oncol Lett. 2025 Sep 1;30(5):506. doi: 10.3892/ol.2025.15252. eCollection 2025 Nov.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.预测肾细胞癌患者肾切除术后的复发和生存:一项基于人群的前瞻性研究及多中心验证。
Int J Surg. 2024 Feb 1;110(2):820-831. doi: 10.1097/JS9.0000000000000935.
6
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
7
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.
8
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
The Predictive Value of the Cholesterol-to-Natural Killer Cell Ratio in Colorectal Cancer.胆固醇与自然杀伤细胞比值在结直肠癌中的预测价值
J Cancer. 2025 Jun 23;16(9):2946-2958. doi: 10.7150/jca.114813. eCollection 2025.

本文引用的文献

1
Characterization and comparative profiling of piRNAs in serum biopsies of pediatric Wilms tumor patients.小儿肾母细胞瘤患者血清活检中piRNA的特征分析与比较概况
Cancer Cell Int. 2025 Apr 26;25(1):163. doi: 10.1186/s12935-025-03780-4.
2
Staging and Restaging Pediatric Abdominal and Pelvic Tumors: A Practical Guide.小儿腹部和盆腔肿瘤的分期和再分期:实用指南。
Radiographics. 2024 Jun;44(6):e230175. doi: 10.1148/rg.230175.
3
Bilateral Wilms tumor: 10-year experience from a single center in China.双侧肾母细胞瘤:来自中国单一中心的10年经验。
Transl Cancer Res. 2024 Feb 29;13(2):879-887. doi: 10.21037/tcr-23-1428. Epub 2024 Feb 27.
4
Prognostic role of primary tumor size in Wilms tumor.原发肿瘤大小在肾母细胞瘤中的预后作用。
Oncol Lett. 2024 Feb 19;27(4):164. doi: 10.3892/ol.2024.14297. eCollection 2024 Apr.
5
Hallmark discoveries in the biology of Wilms tumour.威尔姆斯瘤生物学中的标志性发现。
Nat Rev Urol. 2024 Mar;21(3):158-180. doi: 10.1038/s41585-023-00824-0. Epub 2023 Oct 17.
6
Children's Oncology Group's 2023 blueprint for research: Renal tumors.儿童肿瘤学组 2023 年研究蓝图:肾肿瘤。
Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30586. doi: 10.1002/pbc.30586. Epub 2023 Jul 21.
7
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.循环肿瘤 DNA 作为 III 期和 IV 期肾母细胞瘤患者的生物标志物:来自儿童肿瘤学组试验的分析,AREN0533。
J Clin Oncol. 2022 Sep 10;40(26):3047-3056. doi: 10.1200/JCO.22.00098. Epub 2022 May 17.
8
A Nomogram for Predicting Cancer-Specific Survival in Children With Wilms Tumor: A Study Based on SEER Database and External Validation in China.一种预测肾母细胞瘤患儿癌症特异性生存的列线图:基于监测、流行病学和最终结果(SEER)数据库的研究及在中国的外部验证
Front Public Health. 2022 Apr 7;10:829840. doi: 10.3389/fpubh.2022.829840. eCollection 2022.
9
Wilms tumour.威尔姆斯瘤。
Nat Rev Dis Primers. 2021 Oct 14;7(1):75. doi: 10.1038/s41572-021-00308-8.
10
Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.第一代儿童肿瘤学组临床试验对肾母细胞瘤临床实践的影响。
J Natl Compr Canc Netw. 2021 Aug 1;19(8):978-985. doi: 10.6004/jnccn.2021.7070.